ContraFect contrafect.com


Public list: BIO 2016 (619) Pharma Startups (6570)

ContraFect is a biotechnology company committed to developing technologies, treatments, and products that will target and kill the most virulent and resistant microorganisms-including gram-positive bacteria, such as Staphylococcus (MRSA), and viruses, such as Influenza. These therapeutics will remain active regardless of future resistance to synthetic therapies, such as occurs with antibiotics. ContraFect's Mabs target conserved regions on microbes, bypassing changes in targets due to mutation. ...Show all

ContraFect is a biotechnology company committed to developing technologies, treatments, and products that will target and kill the most virulent and resistant microorganisms-including gram-positive bacteria, such as Staphylococcus (MRSA), and viruses...Show all

Company (IPO / Went public)

All investors data 3 Investors

Phone: 212-359-9553

Fax:

28 Wells Avenue

 Yonkers, 10701
 New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ContraFect $38.7M Dec 10, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ContraFect Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Board Members

Name Firm
Login to see detailsEquity Source Partners
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Bacteriophage lysin and antibiotic combinations against gram positive bacteria Jun 04, 2013 Feb 13, 2018 Patent
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria Mar 09, 2015 Aug 15, 2017 Patent
Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy Sep 16, 2016 Aug 01, 2017 Patent
Biofilm prevention, disruption and treatment with bacteriophage lysin May 09, 2013 Nov 22, 2016 Patent
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria Jan 05, 2011 Apr 14, 2015 Patent
See all 9 patents